THROMBOTIC MICROANGIOPATHY
Clinical trials for THROMBOTIC MICROANGIOPATHY explained in plain language.
Never miss a new study
Get alerted when new THROMBOTIC MICROANGIOPATHY trials appear
Sign up with your email to follow new studies for THROMBOTIC MICROANGIOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with rare transplant complication: drug shows promise in trial
Disease control CompletedThis study tested a drug called ravulizumab in 41 children who developed a serious blood clotting condition (TMA) after a stem cell transplant. The goal was to see if the drug could help normalize blood counts and kidney function. The treatment lasted 26 weeks, and children were …
Matched conditions: THROMBOTIC MICROANGIOPATHY
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
New hope for stem cell transplant patients facing dangerous blood clots
Disease control CompletedThis study tested a drug called ravulizumab in 148 people aged 12 and older who developed a serious blood clotting condition (thrombotic microangiopathy) after a stem cell transplant. The goal was to see if the drug could help patients live longer and avoid worsening of their con…
Matched conditions: THROMBOTIC MICROANGIOPATHY
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 20, 2026 11:54 UTC